Reflexion Pharmaceuticals

Business Services · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Manufacturing Pharmaceuticals Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Reflexion Pharmaceuticals

Use tab to navigate through the menu items. AN ENTIRELY NEW CLASS OF THERAPEUTICS: SYNTHETIC D-PROTEINS Reflexion Pharmaceuticals has developed a novel platform utilizing the tools of synthetic biology to discover, develop and deliver an exciting new class of drug products: proteins composed entirely of D-amino acids. Synthetic D-proteins retain the benefits of antibodies while overcoming many of their limitations including reduced visibility, reduced size, improved stability and unique functionality. We believe our platform has enormous potential as synthetic D-proteins can be made to over 80% of the proteins currently targeted by antibody drugs, as well as additional targets. Reflexion has developed a platform utilizing the tools of synthetic chemical biology to discover, develop and deliver an entirely new class of therapeutics: novel synthetic D-proteins. These synthetic D-proteins are expected to exhibit many of the benefits of monoclonal antibodies while overcoming many of theirRead more
Reflexion Pharmaceuticals's Social MediaPopular SearchesReflexion PharmaceuticalsReflexion Pharmaceuticals isSIC Code 87,873NAICS Code 54,541Show more

Is Reflexion Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Reflexion Pharmaceuticals

Compare insights from companies similar to Reflexion Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Reflexion Pharmaceuticals

<$5M
1-10
Private
-
-
N/A
$10.5M
1-10
Private
-
2010
GX
Gaoping XiaoVice President, Business Development
$6.1M
11-50
Private
-
2008
CL
Cynthia LuManaging Director, Business Development
$5.4M
11-50
Private
-
2013
GC
Guoqing ChenPresident & CEO
<$5M
11-50
Private
-
1996
KD
Krisha DoshiManager, Product Marketing
<$5M
11-50
Private
<$5M
2011
JH
Joyce HuaMarketing Specialist
<$5M
11-50
Private
-
2015
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Reflexion Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Reflexion Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Reflexion Pharmaceuticals.

Reflexion Pharmaceuticals Tech Stack

A closer look at the technologies used by Reflexion Pharmaceuticals

Top Business Services Companies

Frequently Asked Questions Regarding Reflexion Pharmaceuticals

What is Reflexion Pharmaceuticals's official website?
Reflexion Pharmaceuticals's official website is www.reflexionpharma.com
What is Reflexion Pharmaceuticals's Revenue?
Reflexion Pharmaceuticals's revenue is <$5 Million
What is Reflexion Pharmaceuticals's SIC code?
Reflexion Pharmaceuticals's SIC: 87,873
What is Reflexion Pharmaceuticals's NAICS code?
Reflexion Pharmaceuticals's NAICS: 54,541
How many employees does Reflexion Pharmaceuticals have?
Reflexion Pharmaceuticals has 1-10 employees
What industry does Reflexion Pharmaceuticals belong to?
Reflexion Pharmaceuticals is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What is Reflexion Pharmaceuticals competition?
Reflexion Pharmaceuticals top competitors include: ExonBIO, Biologics International, LifeTein, Revitope Oncology
What technology does Reflexion Pharmaceuticals use?
Some of the popular technologies that Reflexion Pharmaceuticals uses are: Google Cloud DNS, Google Cloud Platform, Sectigo, The USERTRUST Network
What does Reflexion Pharmaceuticals do?

Use tab to navigate through the menu items. AN ENTIRELY NEW CLASS OF THERAPEUTICS: SYNTHETIC D-PROTEINS Reflexion Pharmaceuticals has developed a novel platform utilizing the tools of synthetic biology to discover, develop and deliver an exciting new class of drug products: proteins composed entirely of D-amino acids. Synthetic D-proteins retain th... e benefits of antibodies while overcoming many of their limitations including reduced visibility, reduced size, improved stability and unique functionality. We believe our platform has enormous potential as synthetic D-proteins can be made to over 80% of the proteins currently targeted by antibody drugs, as well as additional targets. Reflexion has developed a platform utilizing the tools of synthetic chemical biology to discover, develop and deliver an entirely new class of therapeutics: novel synthetic D-proteins. These synthetic D-proteins are expected to exhibit many of the benefits of monoclonal antibodies while overcoming many of their limitations, including reduced biological visibility, reduced size, improved stability and unique functionality. The chemical synthesis of proteins was pioneered by our co-founder Dr. Stephen Kent. In a landmark paper, Dr. Kent showed that a chemically made protease comprised entirely of D-amino acids recognized and broke down its D-amino acid target peptide. Importantly, D-proteins are not broken down by naturally evolved proteases and are therefore biologically invisible, suggesting that a D-amino acid world (a parallel molecular universe) can be created to be less visible to human proteases and the human immune system. Reflexion believes it has opened a window between these mirror image worlds and can now discover synthetic D-proteins that can interact with drug targets in the L-world to create an entirely new class of therapeutics. Our novel platform integrates advanced chemical protein synthesis methods with in vitro and in silico protein engineering technologies to explore vast libraries of potential D-proteins. Using ...Read More

What are Reflexion Pharmaceuticals social media links?
Reflexion Pharmaceuticals Linkedin page Reflexion Pharmaceuticals Twitter page Reflexion Pharmaceuticals Facebook page
Is Reflexion Pharmaceuticals a public company?
Reflexion Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Reflexion Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.